Alternative in Beta Blocker Intolerance; the ABBI Trial.
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2013
At a glance
- Drugs Nebivolol (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions
- Acronyms ABBI
- 28 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 10 Sep 2010 Planned end date changed from 1 Jan 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 14 May 2009 New trial record